Table 1 Characteristics of the participants from the DD2 cohort of individuals newly diagnosed with type 2 diabetes according to age- and sex corrected YKL-40 percentile categories.

From: YKL-40 and risk of incident cancer in early type 2 diabetes: a Danish cohort study

Covariates

Strata

Age and sex corrected YKL-40 percentile categories

 
  

0–33%

34–66%

67–90%

91–95%

96–100%

Overall

Number of participants

(N = 2975)

(N = 2970)

(N = 2160)

(N = 451)

(N = 454)

9010

Age, years

59.96 (11.37)

60.44 (11.58)

60.67 (11.54)

60.81 (11.40)

60.94 (11.85)

60.38 (11.51)

Sex

 

Female

1223 (41.1%)

1222 (41.1%)

889 (41.2%)

185 (41.0%)

187 (41.2%)

3706 (41.1%)

 

Male

1752 (58.9%)

1748 (58.9%)

1271 (58.8%)

266 (59.0%)

267 (58.8%)

5304 (58.9%)

Family history of diabetesa

 

Noa

1089 (36.6%)

1087 (36.6%)

876 (40.6%)

184 (40.8%)

199 (43.8%)

3435 (38.1%)

 

Yes

1886 (63.4%)

1883 (63.4%)

1284 (59.4%)

267 (59.2%)

255 (56.2%)

5575 (61.9%)

Diabetes duration, years

1.78 (2.23)

1.78 (2.23)

1.83 (2.51)

1.80 (2.39)

1.97 (2.59)

2.04 (2.57)

Body mass index, kg/m²

30.37 (5.66)

30.37 (5.66)

31.45 (5.97)

32.74 (6.66)

33.11 (7.93)

32.54 (7.03)

 

Missing

1020 (34.3%)

990 (33.3%)

691 (32.0%)

144 (31.9%)

147 (32.4%)

2992 (33.2%)

Waist-to-hip ratio

0.97 (0.09)

0.98 (0.09)

0.99 (0.08)

0.99 (0.09)

1.00 (0.08)

0.98 (0.09)

 

Missing

33 (1.1%)

33 (1.1%)

29 (1.3%)

8 (1.8%)

6 (1.3%)

109 (1.2%)

Alcohol overconsumptiona

 

No

2858 (96.1%)

2853 (96.1%)

1986 (91.9%)

393 (87.1%)

353 (77.8%)

8443 (93.7%)

 

Yes

117 (3.9%)

117 (3.9%)

174 (8.1%)

58 (12.9%)

101 (22.2%)

567 (6.3%)

Smoking status

 

Never smoker

1055 (35.5%)

1028 (34.6%)

703 (32.5%)

132 (29.3%)

126 (27.8%)

3044 (33.8%)

 

Ever smoker

1012 (34.0%)

997 (33.6%)

732 (33.9%)

184 (40.8%)

175 (38.5%)

3100 (34.4%)

 

Missing

908 (30.5%)

945 (31.8%)

725 (33.6%)

135 (29.9%)

153 (33.7%)

2866 (31.8%)

Physical activitya

 

Low

2298 (77.2%)

2386 (80.3%)

1766 (81.8%)

372 (82.5%)

379 (83.5%)

7201 (79.9%)

 

High

677 (22.8%)

584 (19.7%)

394 (18.2%)

79 (17.5%)

75 (16.5%)

1809 (20.1%)

HbA1c, mmol/mol

50.36 (11.38)

50.67 (11.32)

52.42 (12.58)

53.30 (13.67)

52.74 (12.62)

51.24 (11.90)

 

Missing

507 (17.0%)

496 (16.7%)

322 (14.9%)

55 (12.2%)

46 (10.1%)

1426 (15.8%)

HOMA2-B, %

97.52 (43.62)

99.41 (43.60)

103.52 (46.04)

99.83 (46.92)

99.09 (44.94)

99.78 (44.49)

 

Missing

181 (6.1%)

184 (6.2%)

127 (5.9%)

33 (7.3%)

41 (9.0%)

566 (6.3%)

HOMA2-S, %

41.92 (21.05)

38.32 (18.85)

34.79 (18.54)

34.93 (21.87)

32.99 (19.19)

38.23 (19.93)

 

Missing

181 (6.1%)

184 (6.2%)

127 (5.9%)

33 (7.3%)

41 (9.0%)

566 (6.3%)

UACR, mg/g

26.55 (108.64)

39.21 (153.43)

56.18 (210.28)

59.11 (256.96)

183.93(1083.88)

48.11 (300.00)

 

Missing

1220 (41.0%)

1143 (38.5%)

829 (38.4%)

166 (36.8%)

158 (34.8%)

3516 (39.0%)

eGFR, mL/min/1.73 m²

89.28 (16.16)

87.70 (18.18)

86.96 (19.63)

87.19 (20.10)

85.89 (22.34)

87.91 (18.31)

 

Missing

734 (24.7%)

710 (23.9%)

466 (21.6%)

81 (18.0%)

78 (17.2%)

2069 (23.0%)

LDL cholesterol, mmol/L

2.32 (0.88)

2.32 (0.91)

2.28 (0.92)

2.28 (0.89)

2.30 (1.01)

2.31 (0.90)

 

Missing

862 (29.0%)

870 (29.3%)

608 (28.1%)

125 (27.7%)

104 (22.9%)

2569 (28.5%)

Triglycerides, mmol/L

1.87 (1.66)

2.01 (1.41)

2.23 (1.69)

2.45 (1.61)

2.34 (1.67)

2.06 (1.60)

 

Missing

874 (29.4%)

886 (29.8%)

608 (28.1%)

122 (27.1%)

104 (22.9%)

2594 (28.8%)

C-reactive protein, mg/L

2.73 (4.39)

3.85 (6.76)

4.83 (7.38)

6.21 (9.24)

6.65 (10.60)

3.97 (6.76)

 

Missing

51 (1.7%)

50 (1.7%)

46 (2.1%)

<10 ( < 2.0%)

<10 ( < 2.0%)

159 (1.8%)

YKL-40, µg/L

21.51 (6.99)

41.32 (11.38)

77.98 (26.99)

144.89 (41.99)

328.60 (264.08)

63.23 (92.17)

  1. Values were collected at (or close to) enrolment during 2010 through 2023, and expressed as numbers of participants (frequencies), or means (standard deviations).
  2. DD2 The Danish Centre for Strategic Research in Type 2 Diabetes, HbA1c glycated haemoglobin, HOMA2-B and HOMA2-S homoeostasis model assessment of β-cell function and insulin sensitivity, UACR urinary albumin-to-creatinine ratio, eGFR estimated glomerular filtration rate, LDL low density lipoprotein.
  3. aFamily history of diabetes was missing for 48 individuals, alcohol overconsumption for 29, and physical activity for 50. To address the issue of very small numbers (n < 5), i.e., microdata prohibited by the Danish Health Authority, missing values were, for this table only, re-coded to “No” for family history of diabetes, “No” for alcohol overconsumption, and “Low” for physical activity.